Dopaminergic agonist and antagonist effects on striatal tyrosine hydroxylase distribution (original) (raw)
Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol
John Haycock
European Journal of Neuroscience, 2004
View PDFchevron_right
Characterization of haloperidol-mediated effects on rat striatal tyrosine hydroxylase
sikta pradhan
Neuropharmacology, 1981
View PDFchevron_right
Brain tyrosine level controls striatal dopamine synthesis in haloperidol-treated rats
MICHAEL SCALLY
Journal of Neural Transmission, 1977
View PDFchevron_right
Evidence for a functional coupling between dopamine reuptake and tyrosine hydroxylation in striatal nerve terminals
Guido Maura
Neurochemistry International, 1982
View PDFchevron_right
Is Dopamine-Induced Inhibition of Adenylate Cyclase Involved in the Autoreceptor-Mediated Negative Control of Tyrosine Hydroxylase in Striatal Dopaminergic Terminals?
S. Mestikawy
Journal of Neurochemistry, 1986
View PDFchevron_right
Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid
Pier Franco Spano
Brain Research, 1977
View PDFchevron_right
Poor evidence for depolarization block but uncoupling of nigral from striatal dopamine metabolism after chronic haloperidol treatment in the rat
Stanisław Chrapusta
Journal of Neural Transmission, 2006
View PDFchevron_right
Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat
George Jaskiw
Psychopharmacology, 2004
View PDFchevron_right
Reduced striatal tyrosine hydroxylase activity is not accompanied by change in responsiveness of dopaminergic receptors following chronic treatment with deprenyl
John Finberg
Neuropharmacology, 1997
View PDFchevron_right
Formation and Metabolism of Dopamine in Nine Areas of the Rat Brain: Modifications by Haloperidol
fokko bosker
Journal of Neurochemistry, 1984
View PDFchevron_right
Tyrosine Hydroxylase Content of Residual Striatal Dopamine Nerve Terminals Following 6-Hydroxydopamine Administration: A Flow Cytometric Study
Michael Zigmond
Journal of Neurochemistry, 1989
View PDFchevron_right
Presynaptic Dopamine Autoreceptors Control Tyrosine Hydroxylase Activation in Depolarized Striatal Dopaminergic Terminals
S. Mestikawy
Journal of Neurochemistry, 1986
View PDFchevron_right
Increased Site-Specific Phosphorylation of Tyrosine Hydroxylase Accompanies Stimulation of Enzymatic Activity Induced by Cessation of Dopamine Neuronal Activity
emanuel meller
Molecular Pharmacology, 1999
View PDFchevron_right
[3H]DOPA Formed From [3H]Tyrosine in Living Rat Brain Is Not Committed to Dopamine Synthesis
Albert Gjedde
Journal of Cerebral Blood Flow & Metabolism, 1998
View PDFchevron_right
Effects of haloperidol on the activity and membrane physiology of substantia nigra dopamine neurons recorded in vitro
Anthony Grace
Brain Research, 1996
View PDFchevron_right
Activation of soluble striatal tyrosine hydroxylase in the rat brain after CDPcholine administration
Henry Pacheco
Biochemical Pharmacology, 1981
View PDFchevron_right
SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase
MC Olianas
Brain research, 1985
View PDFchevron_right
Stoichiometry of Tyrosine Hydroxylase Phosphorylation in the Nigrostriatal and Mesolimbic Systems In Vivo
John Haycock
Journal of Neurochemistry, 2001
View PDFchevron_right
Lack or Inhibition of Dopaminergic Stimulation Induces a Development Increase of Striatal Tyrosine Hydroxylase-Positive Interneurons
Luca Zangrandi, Roberto Gradini, Domenico Bucci
PLoS ONE, 2012
View PDFchevron_right
Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis
Trevor Sharp
European journal of pharmacology, 1984
View PDFchevron_right
The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT2A and 5-HT2C receptor subtypes and significance of the haloperidol dose used
Guillaume Lucas
Neuropharmacology, 2000
View PDFchevron_right
Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity
Anthony Grace
Life Sciences, 1978
View PDFchevron_right
Striatal extracellular dopamine levels in rats with haloperidol-induced depolarization block of substantia nigra dopamine neurons
Anthony Grace
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience
View PDFchevron_right
Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A 2 and dopamine D 2 receptors in the neostriatum
Per Snaprud
…, 1994
View PDFchevron_right
Modulation of the endogenous acetylcholine release from rat striatal slices
J. Marsal
Brain Research, 1985
View PDFchevron_right
Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum
Perry Molinoff
Proceedings of the National Academy of Sciences, 1982
View PDFchevron_right
Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol
d burt
Life Sciences, 1975
View PDFchevron_right
Tyrosine loading increases dopamine metabolite concentrations in the brain
Teri Foley-Nelson
Pharmacology Biochemistry and Behavior, 1990
View PDFchevron_right
Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade
Fabio Benfenati
Brain Research, 1987
View PDFchevron_right
Dopamine Release in Rat Striatum: Physiological Coupling to Tyrosine Supply
Ian Acworth
Journal of Neurochemistry, 1989
View PDFchevron_right
Effects of 5,6-dihydroxytryptamine on tyrosine-hydroxylase activity in central catecholaminergic neurons of the rat
Bernard Renaud
Biochemical Pharmacology, 1975
View PDFchevron_right
Effect of co administration of haloperidol and large neutral amino acids (tryptophan and valine) on rats striatal dopamine, serotonin and their metabolism
Obaid Ali
Pakistan Journal of Pharmaceutical Sciences, 2003
View PDFchevron_right
Tyrosine hydroxylase, aromatic l-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs
A. Duchemin
Brain Research, 1999
View PDFchevron_right